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Abstract
Currently,  a  pharmacological  disease-modifying  treatment  for  dementia  is  not
available, but different non-pharmacological approaches appear to be useful. In this
chapter, we describe traditional treatments such as cognitive and emotion-oriented
interventions, sensory and multi-sensory stimulation interventions and also potential‐
ly alternative interesting options such as behavioural therapy, animal-assisted therapy,
home-adaptation therapy and assistive technologies to support patient with demen‐
tia.  Many  non-pharmacological  treatments  have  reported  benefits  in  multiple  re‐
search studies, but there is a need for further Randomized controlled trials (RCTs) with
an adequate sample size to improve the strength of evidence in order to apply these
approaches.
Keywords: dementia, neuropsychiatric symptoms, activities of daily living, cognitive
and emotion-oriented interventions, sensory and multi-sensory stimulation interven‐
tions
1. Introduction
Dementia is a term that describes disorders causing cognitive impairment capable to signifi‐
cantly affect functional status [1]. Worldwide, 46.8 million people have dementia, and every
year, there are over 9.9 million new diagnosed cases [2], with a total global societal costs of US
$ 604 billion in 2010 [2]. Alzheimer’s disease (AD) is the most common form of dementia [3]
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and represents  one of  the  major  causes  of  disability,  dependency,  burden and stress  of
caregivers increasing institutionalization among older people worldwide [4].
This condition also leads to severe social consequences: decreased quality of life and well-
being, increased family burdens and healthcare demand and longer term utilization of care
facilities that generate very significant impacts on healthcare services demand and conse‐
quently costs [5]. The symptoms of dementia are grouped under three main headings: cog‐
nitive aspects, functional aspects and neuropsychiatric symptoms (NPSs). Dementia is a
disease characterized by a cognitive decline involving one or more cognitive domains
(memory and learning, executive function, language, complex attention, perceptual-motor,
social cognition, etc.) [6]. The deficits must correspond to a decline from previous level of
function and could be severe enough to interfere with daily functions and independence.
Memory impairment is one of the main cognitive issues that contribute to the inability to
live independently [4, 7, 8]. In the early stages of AD, it limits memory processes and re‐
duces older people’s autonomy in performing more complex daily activities, and it concur‐
rently causes deterioration of emotional control, social behaviour and motivation [4, 6].
The functional aspects can be described in two broad classes: (1) basic activities of daily living
or BADL [9, 10] and (2) instrumental activities of daily living or IADL [11]. BADLs are physical
tasks essential to maintaining the independence and include the ability to go to the toilet, feed,
dress, groom, bathe and ambulate. IADLs are activities typically more cognitively demanding
than BADL and include the ability to successfully use the telephone, shop, prepare food, do
the housekeeping and laundry, manage medications and finances and use transportation
outside of the home (e.g., driving a car, using public transit or riding in a taxi). In the early
stage of dementia, most patients are independent with BADL, but they begin to need help with
some IADLs [12]. In the moderate phase, cooking, housework and shopping require direct
assistance, and BADL require assistance for set-up and safety. Moreover, the presence of NPS
could increase anger, frustration and difficulty in communicating needs [13]. As dementia
enters the severe stage, independence is progressively lost and caregivers must offer consistent
direct care with most if not all BADL [14–17].
NPS are common features of Alzheimer’s disease (AD) [18, 19] and are one of the major risk
factors for institutionalization [20]. NPS may be correlated to AD independently of cognitive
impairment severity or emerge in the course of the illness being a significant cause of a more
rapid cognitive decline [21]. It was found that over 80% of AD patients had NPS in the history
of the illness [21, 22]. Four separate neuropsychiatric syndromes were identified: hyperactive,
psychotic, affective and apathetic [19, 23]. In particular, agitation, euphoria, disinhibition,
irritability and aberrant motor behaviour were defined as hyperactive syndrome; delusions,
hallucinations and night-time disturbances as psychotic syndrome; depression and anxiety as
affective syndrome, and apathy and eating abnormalities as apathetic syndrome.
Currently, there is no effective disease-modifying cure, and treatment is directed mainly to
manage the symptoms of dementia [24].
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The limited efficacy of the drug therapy and the plasticity of the human brain are the two most
important reasons that explain the growing interest in non-pharmacological intervention for
dementia patients.
Several non-pharmacological treatments targeting cognitive, functional and neuropsychiatric
aspects have been proposed for patients with dementia [25, 26].
This chapter describes the most used non-pharmacological treatment for dementia in accord‐
ing to the best-practice recommendations in the research literature [27–30] and the Standards
for the Reporting of Diagnostic accuracy studies in dementia (STARDdem) [31].
2. Methods
A narrative review was performed using qualitative data and best-practice recommendations
in the research literature [32, 33]. The searches were performed in the MEDLINE, PubMed,
EMBASE, CINAHL and PsycINFO databases.
The search queries included ‘dementia’, ‘non-pharmacological treatment’ and ‘cognitive
rehabilitation’, and were limited to English language articles.
The inclusion/exclusion criteria used for this review protocol are the following.
Inclusion criteria were as follows: (1) age ≥60 years, (2) diagnosis of dementia according to the
criteria of the National Institute on Aging-Alzheimer’s Association (NIAAA) [34], (3) use of
non-pharmacological tools to treat the cognitive and functional impairment in dementia and
(4) acceptable clinical measures of cognitive impairment, disability, quality of life and global
clinical assessments.
Exclusion criteria were as follows: (1) no English editing (because we had no resources for
translation) and (2) diagnosis of non-dementia.
Quality of study reporting was assessed using the Standards for the Reporting of Diagnostic
accuracy studies in dementia (STARDdem) [35].
3. Cognitive and emotion-oriented interventions
Cognitive and emotion-oriented care approach seeks to improve cognitive, emotional and
social functioning by supporting patients with dementia [36]. The treatments commonly used
are reminiscence therapy, reality orientation therapy and validation therapy.
3.1. Reminiscence therapy
Reminiscence therapy is a common and widely diffused intervention in dementia care
although based on a few high-quality and sufficiently robust studies. Two studies explored
group reminiscence [37, 38]. A study evaluated effects on neuropsychiatric and cognitive
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symptoms [37]. Another reminiscence group intervention [38] evaluated effectiveness in
preventing cognitive impairment progression and enhancing affective function. The results
showed improvement in most variables including cognition and depression than controls.
3.2. Reality orientation therapy
Reality orientation (RO) is a technique of cognitive stimulation [39, 40]. It entails presenting
the patient by continuous memory and orientation information associated with personal
environment and issues. Several methods of implementing RO have been explained [40–42].
Throughout the treatment sessions, the patient is supported to talk about various arguments
linked to his daily routine and recent events. Encouraging the patient to connect socially is a
very significant component of the therapy [40, 42, 43]. Following the first publication of a
review about RO, interest in the subject increased dramatically and most subsequent articles
reported substantial benefits following the use of these strategies [40, 42, 44].
RO focuses on new cognitive stimulation strategies emerged in recent studies. The cognitive
stimulation therapy (CST) is an example [40, 45]. Beyond the features assessed in RO, the CST
is based also on multi-sensory stimulation and reminiscence [40, 44, 46].
Some reviews about RO confirmed earlier findings of substantial benefits and also identified
existing and new areas where further work is required [39–41].
3.3. Validation therapy
The validation therapy (VT) was developed stages: to address the shortcomings of other
approaches, such as RO, in approaching patients who have more advanced dementia. The VT
was the result of an attempt to provide practical solutions for difficulties experienced by
patients and caregivers.
Important characteristics of VT include: means of classifying behaviours, provision of simple,
practical techniques that help restore dignity, provision of an empathic listener, respect and
empathy for older adults with dementia and acceptance of the person’s reality [47].
The way in which these rules are applied to provide specific interventions depends on the
dementia severity categorized into mal orientation, time confusion, repetitive motion and
vegetation. Each stage is recognized through defined cognitive and behavioural features and
defined VT interventions address the various cognitive and neuropsychiatric characteristics
showed by dementia people at each stage [47]. Various observational studies have indicated
that the application of VT determine positive effects about amount and duration of interactions
that participants are able to make during validation groups session [48, 49]. Though, other
studies showed no significant effects of VT [50].
4. Sensory and multi-sensory stimulation interventions
Sensory stimulation and multi-sensory stimulation refer to a variety of techniques used to
stimulate the senses in order to increase alertness and reduce agitation [51]. Sensory stimula‐
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tion includes auditory, visual, olfactory, tactile, taste and kinaesthetic stimulation [52, 53].
Several studies examined sensorial and multi-sensorial interventions. In this chapter, seven
therapy types were identified.
4.1. Art therapy
Art therapy is the therapeutic use of art making within a professional relationship. It has been
suggested as a treatment for people with dementia as it has the potential to provide meaningful
stimulation, improve social interaction and improve levels of self-esteem [54]. Activities such
as drawing and painting are thought to provide individuals the opportunity for self-expression
and the chance to exercise some choices in terms of the colours and themes of their creations.
4.2. Music therapy
Music therapy is defined as the clinical and evidence-based use of music interventions to
accomplish individualized goals within a therapeutic relationship by a credentialed profes‐
sional [55]. Two studies showed the effect of music on neuropsychiatric symptoms [56, 57]. It
was tested a live-music intervention on decreasing anxiety and agitation [55]. Results showed
no significant differences in anxiety and agitation. However, a study [56] showed a statistically
significant decrease of the agitation in a group music-listening intervention.
4.3. Occupational therapy
The primary focus of occupational therapy (OT) is to improve patients’ ability to perform
activities of daily living, promote independence, reduce caregiver burden and ultimately
improve quality of life.
OT offers interventions associated with awareness of self-care, leisure activities, occupational
identity and productivity [58]. Studies showed an association between cognitive impairment
and occupational performance [59, 60]. Therefore, patients with dementia can be assisted
through OT trying to preserve an adequate performance level in BADL and IADL [61].
Furthermore, caregivers can adopt OT techniques, in the family or institution, to stimulate
patient performing daily activities, preventing disruptive behaviour, wandering and aggres‐
sion.
4.4. Aromatherapy
Aromatherapy is the fastest growing of all complementary therapies, in terms of public interest
[62]. It aids interaction while providing a sensory experience. Aromatherapy appears to have
several advantages over the pharmacological treatments used for dementia [63]. It seems to
be well tolerated in comparison with sedative or neuroleptic medication [63]. The two essential
oils used in aromatherapy for dementia patients are extracted from lavender and Melissa balm
and could be administered in numerous methods such as bathing, inhalation, massage and
topical application in cream [63]. Aromatherapy can be addressed to patients with several
behaviours. Recent controlled trials showed significant reductions in agitation, with excellent
compliance and tolerability [63–65].
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4.5. Bright-light therapy
Bright light therapy (BLT) consists of exposure to daylight or specific wavelengths of light
using polychromatic polarised light, laser, light-emitting diodes, fluorescence lamps, dichroic
lamps or very bright, full-spectrum light. Four studies tested the effect of BLT on behavioural
symptoms [66–69]. Two studies compared the effect of morning BLT and afternoon/evening
BLT with normal light [66, 67]. Other studies compared one single type of BLT with usual light
[66], and no differences were found between morning and evening. Limited evidence of
reduction in agitation and aggression among those receiving BLT was found [67, 70].
4.6. Activity therapy
Activity therapy (AT) implicates recreation activities such as dance, sport and drama. It was
found that physical exercise can have health benefits for dementia patients, reducing the
number of falls and improving mental health, sleep [63, 70] and mood [71]. In addition, it was
found that daytime exercise aided to decrease daytime agitation and night-time restlessness
[63, 72]. Perrin described an interesting approach to dance therapy: he employed a form of
dance known as ‘jabadeo’, which allows the patients to engage with each other in interactive
movements [63, 73].
4.7. Snoezelen multi-sensory stimulation
Snoezelen is a multi-sensory setting for implementation of several sensory-based tools.
Snoezelen offers sensory stimuli to primary senses of hearing, touch, sight, smell and taste, by
the use of music, odour of essential oils, lighting effects and tactile surfaces [74]. Several studies
define snoezelen approach as a support therapy for dementia patients [75]. The goals of such
therapy are to promote positive behaviours and to reduce maladaptive behaviours [76, 77].
Over the past decade, the clinical application of Snoezelen has been extended from the field
of learning disability to dementia care. Its use resides in providing a sensory environment that
capitalizes on the residual sensorimotor abilities of dementia patients. Moreover, encouraging
results were obtained in the area of promoting adaptive behaviours [78]. In practice, snoezelen
capitalize on the residual sensorimotor abilities of dementia sufferers and present a few
attentional and intellectual demands [76].
5. Other interventions
5.1. Behavioural therapy
Traditionally, behavioural therapy has been based on principles of conditioning and learning
theory using strategies aimed at suppressing or eliminating challenging behaviours. More
recently, positive programming methodologies [79] have used non-aversive methods in
helping to develop more functional behaviours. Moniz-Cook suggests that behavioural
analysis is often the starting point of most other forms of therapeutic intervention in this area
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[80] and can be wholly consistent with person-centred care. Behavioural therapy requires a
period of detailed assessment in which the triggers, behaviours and reinforcers are observed
and their relationships made clear to the patient. The therapists use chart or diary to collect
information about the behavioural symptoms, and interventions are based on an analysis of
these findings.
For Emerson, planning an intervention should be focussed on three key features: identifying
the individual’s preferences; changing the context in which the behaviour occurs; and using
reinforcement strategies and schedules that reduce the behaviour [63, 81].
A few studies showed the efficacy of behavioural in the context of dementia [63, 82]. There is
some evidence of successful reductions in wandering, incontinence and other forms of
stereotypical behaviours [83].
5.2. Animal-assisted therapy
Animal-assisted therapy (AAT) most commonly involves interaction between a patient and a
trained animal, facilitated by a human handler, with a therapeutic goal such as providing
relaxation and pleasure, or incorporating activities into physical therapy or rehabilitation. The
therapeutic effect has been described by Baun and McCabe with reference to the stage of
dementia and the positive effect on caregivers [84]. A review showed that AAT may ameliorate
NPS in patients with dementia [85].
5.3. Home adaptation therapy
Home modifications for patients with dementia should promote safety for the patient and
peace of mind for the caregiver. The modifications allow patients with dementia to receive
ongoing care in the least restrictive environment possible and may be implemented as the need
arises [86]. Home modifications for patients with dementia are associated with improved
caregiver effectiveness and less caregiver upset [87].
5.4. Assistive technologies
In recent years, there have been significant innovations in the application of assistive technol‐
ogies (ATs) to support healthcare for patients with dementia. These technologies can be used
by the patients with dementia, by the caregivers, and can run automatically (the so-called
‘ambient intelligence’) [88].
AT applications have the potential to support aging in place for patients with dementia, and
they range from internet-based information and support groups to robotic companions
comprising also the use of smartphones to report symptoms [89–91].
Several studies describe the responses of caregivers and patients with dementia (PWD) to
technology [92–94]. In general, the objective of AT is to allow people to remain more inde‐
pendent and reside at home safely [91–93]. In an another study, it was found that involving
the patients with dementia in the process of developing technological applications enhanced
usability and acceptability and contributed to a sense of empowerment [95].
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6. Conclusion
Great efforts have been made to develop strategies to improve the quality of life of dementia
patients. A shared feature is the need to work with systems (families, professional careers,
organisations, etc.) [63]. Care staff and families are regularly integral to treatment strategies
and are essential in obtaining reliable information and constructing appropriate interventions
[63]. It is evident, therefore, that training of carers (both professional and family) is an
important part of most treatment programmes. A study suggested that the most common
interventions for psychological and behavioural symptoms of dementia were not necessarily
specific therapies but working with carers to change the attitudes and behaviour of those in
their care [96]. The field of dementia care is growing, with an increasing number of articles
about psychosocial interventions [63]. Though, there is a fundamental limitation within the
current literature that clearly requires addressing. A care plan that focused on non-pharma‐
cological interventions is considered best practice as the first-line management of most NPS
of dementia. They can significantly improve quality of life and satisfaction of patients with
dementia and their caregivers.
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